- Home
- ROIV vs XP Comparison
ROIV vs XP Comparison
Compare ROIV & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- XP
- Stock Information
- Founded
- ROIV 2014
- XP 2001
- Country
- ROIV United Kingdom
- XP Cayman Islands
- Employees
- ROIV N/A
- XP N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- XP Investment Bankers/Brokers/Service
- Sector
- ROIV Health Care
- XP Finance
- Exchange
- ROIV Nasdaq
- XP Nasdaq
- Market Cap
- ROIV 8.4B
- XP 7.5B
- IPO Year
- ROIV N/A
- XP 2019
- Fundamental
- Price
- ROIV $10.87
- XP $18.64
- Analyst Decision
- ROIV Buy
- XP Buy
- Analyst Count
- ROIV 4
- XP 6
- Target Price
- ROIV $17.50
- XP $22.00
- AVG Volume (30 Days)
- ROIV 5.3M
- XP 7.9M
- Earning Date
- ROIV 05-29-2025
- XP 05-20-2025
- Dividend Yield
- ROIV N/A
- XP 3.49%
- EPS Growth
- ROIV N/A
- XP 15.23
- EPS
- ROIV N/A
- XP 1.51
- Revenue
- ROIV $122,585,000.00
- XP $2,886,046,386.00
- Revenue This Year
- ROIV N/A
- XP $19.79
- Revenue Next Year
- ROIV N/A
- XP $12.65
- P/E Ratio
- ROIV N/A
- XP $12.32
- Revenue Growth
- ROIV 140.04
- XP 9.27
- 52 Week Low
- ROIV $8.73
- XP $10.82
- 52 Week High
- ROIV $13.06
- XP $20.39
- Technical
- Relative Strength Index (RSI)
- ROIV 51.00
- XP 72.66
- Support Level
- ROIV $10.58
- XP $18.30
- Resistance Level
- ROIV $11.07
- XP $19.85
- Average True Range (ATR)
- ROIV 0.30
- XP 0.61
- MACD
- ROIV -0.04
- XP 0.03
- Stochastic Oscillator
- ROIV 30.21
- XP 72.20
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.